Sage Journals: Discover world-class research

Open access

Research article

First published 2024-10

Efficacy of eptinezumab in non-responders to subcutaneous monoclonal antibodies against CGRP and the CGRP receptor: A retrospective cohort study

Paul Triller, Virginia N. Blessing, Lucas H. Overeem [...]

Cephalalgia

Open access

Research article

First published 2024

Real-world effectiveness of add-on fremanezumab in patients receiving onabotulinumtoxinA for the prevention of chronic migraine in a US tertiary headache center: A retrospective chart review study

Hsiangkuo Yuan, Fred Cohen, Maurice T Driessen [...]

Cephalalgia Reports

Free access

Review article

First published 2019-3

CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications

David W Dodick

Cephalalgia

Free access

Correction

First published 2019-7

Corrigendum: CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications

Cephalalgia

Free access

Research article

First published 2019-12

Erenumab (AMG 334),a monoclonal antagonist antibody against the canonical CGRP receptor,does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries

Lena Ohlsson, Kristian A Haanes, Erik Kronvall [...]

Cephalalgia

Free access

Editorial

First published 2019-12

Cardio- and cerebrovascular safety of erenumab,a monoclonal antibody targeting CGRP receptors – important studies on human isolated arteries

Karl Messlinger, Antoinette MaassenVanDenBrink

Cephalalgia

Free access

Research article

First published 2022-10

The monoclonal CGRP-receptor blocking antibody erenumab has different effects on brainstem and cortical sensory-evoked responses

Francesco Casillo, Gabriele Sebastianelli, Antonio Di Renzo [...]

Cephalalgia

Free access

Research article

First published 2014-6

Safety and tolerability of LBR-101,a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program

Marcelo E Bigal, Rafael Escandon, Michele Bronson [...]

Cephalalgia

Free access

Research article

First published 2021-1

Adverse effects of erenumab on cerebral proliferative angiopathy: A case report

Laura L Lehman, Rebecca Bruccoleri, Amy Danehy [...]

Cephalalgia

Free access

Research article

First published 2021-12

Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies

Richard B Lipton, David W Dodick, David Kudrow [...]

Cephalalgia

Search results